Hopeful antioxidant tested to slow blinding eye disease

NCT ID NCT03999021

Summary

This study is checking the long-term safety and side effects of a high-dose antioxidant supplement called N-Acetylcysteine (NAC) in 30 adults with retinitis pigmentosa, a disease that damages vision. The goal is to see if people can safely take this medication twice daily for an extended period, as it is thought to protect delicate eye cells from damage. This is an early-phase study focused on safety, not proving if the treatment works to save vision.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Wilmer Eye Institute at Johns Hopkins University

    Baltimore, Maryland, 21287, United States

Conditions

Explore the condition pages connected to this study.